Skip to content

Patient acceptability and technical robustness of the Elucid Pill Connect system for use in clinical trials

Patient acceptability and technical robustness of the Elucid Pill Connect system for use in clinical trials

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON19951
Enrollment
10
Registered
2019-06-27
Start date
2019-06-28
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Provision of the Elucid Pill Connect System

Sponsors

University Medical Center Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) age >18 years, (2) own an Android or Iphone phone with the required OS versions, (3) are able to operate the mobile phone themselves and (4) provide informed consent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Percentage of pills dispensed according to intended dosing schedule

Secondary

MeasureTime frame
User acceptance (measured with the System Usability Scale and a self-designed questionnaire), investigator acceptance, technical validation (correct logging of dispense data, timing, battery life, sending of reminders, locking and temperature) and comparison with self-reported adherence according to the MARS questionnaire

Contacts

Public ContactJob F.M. van Boven

University Medical Center Groningen

j.f.m.van.boven@umcg.nl+31503617893

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)